SSA
AVNS

Schonfeld Strategic Advisors’s Avanos Medical AVNS Stock Holding History

Schonfeld Strategic Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.03M Buy
+202,268
New +$4.74M 0.02% 641
2026
Q1 		– Sell
-10,824
Closed -$122K – 2213
2025
Q4 		$122K Buy
+10,824
New +$124K ﹤0.01% 1790
2025
Q3 		– Sell
-27,739
Closed -$340K – 2197
2025
Q2 		$340K Buy
+27,739
New +$349K ﹤0.01% 1660
2024
Q2 		– Sell
-11,934
Closed -$238K – 2147
2024
Q1 		$238K Buy
+11,934
New +$231K ﹤0.01% 1734
2022
Q4 		– Sell
-27,358
Closed -$597K – 2581
2022
Q3 		$597K Buy
+27,358
New +$715K 0.01% 1625
2022
Q2 		– Sell
-11,700
Closed -$392K – 2525
2022
Q1 		$392K Buy
+11,700
New +$377K ﹤0.01% 1522
2020
Q4 		– Sell
-69,544
Closed -$2.31M – 1567
2020
Q3 		$2.31M Buy
69,544
+3,142
+5% +$100K 0.04% 466
2020
Q2 		$1.95M Buy
+66,402
New +$1.92M 0.05% 411
2020
Q1 		– Sell
-239,772
Closed -$8.08M – 1140
2019
Q4 		$8.08M Buy
+239,772
New +$8.68M 0.2% 132
2018
Q4 		– Sell
-104,100
Closed -$7.13M – 1051
2018
Q3 		$7.13M Sell
104,100
-45,900
-31% -$2.95M 0.32% 81
2018
Q2 		$8.59M Sell
150,000
-31,575
-17% -$1.67M 0.47% 40
2018
Q1 		$8.37M Buy
181,575
+13,477
+8% +$640K 0.63% 24
2017
Q4 		$7.76M Buy
168,098
+83,954
+100% +$3.86M 0.64% 26
2017
Q3 		$3.79M Buy
+84,144
New +$3.59M 0.35% 94

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Schonfeld Strategic Advisors's AVNS Position: Q2 2026 in Review

Schonfeld Strategic Advisors opened a new position in Avanos Medical (AVNS) in Q2 2026: 202,268 shares worth $5.03M. The stake represents 0.02% of the portfolio and ranks #641 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in AVNS as recently as Q4 2025.

Schonfeld Strategic Advisors first reported a position in AVNS in Q3 2017 and has held it in 14 quarters since. The position peaked at $8.59M in Q2 2018. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Schonfeld Strategic Advisors held 202,268 shares of Avanos Medical worth $5.03M as of Q2 2026.
  • Avanos Medical was a new Schonfeld Strategic Advisors position in Q2 2026.
  • Avanos Medical made up 0.02% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #641 holding.
  • Schonfeld Strategic Advisors first reported a position in Avanos Medical in Q3 2017 and has held it in 14 quarters since.
  • Schonfeld Strategic Advisors's Avanos Medical position peaked at $8.59M in Q2 2018.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.